Author:
Ambrose Paul G.,Meagher Alison K.,Passarell Julie A.,Wart Scott A. Van,Cirincione Brenda B.,Rubino Chris M.,Korth-Bradley Joan M.,Babinchak Timothy,Ellis-Grosse Evelyn
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference12 articles.
1. Monte Carlo simulation in the evaluation of susceptibility breakpoints: predicting the future;Ambrose;Pharmacother,2006
2. Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint;Drusano;Antimicrob. Agents Chemother.,2001
3. Pharmacodynamics in the study of drug resistance and setting of in vitro susceptibility breakpoints: ready for prime time;Dudley;Current. Opin. Microbiol.,2000
4. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the “Pollyanna phenomenon”;Marchant;J. Pediat.,1992
5. Meagher AK, Passarell JA, Liolios K, Van Wart Sam Cirincione BB, Ambrose PG (2005) Estimation of in vitro susceptibility breakpoints for tigecycline against Enterobacteriaceae. In: Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC, American Society for Microbiology, page 22, A–1156.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献